125 related articles for article (PubMed ID: 32353391)
1. Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers.
Abu-Gheida I; Bathala TK; Maldonado JA; Khan M; Anscher MS; Frank SJ; Choi S; Nguyen QN; Hoffman KE; McGuire SE; Kim M; Kuban DA; Aparicio A; Chapin BF; Tang C
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):982-985. PubMed ID: 32353391
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
4. Potential Impact of
Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
[TBL] [Abstract][Full Text] [Related]
5. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
6. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
7. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?
Kim JH; Beets GL; Kim MJ; Kessels AG; Beets-Tan RG
Eur J Radiol; 2004 Oct; 52(1):78-83. PubMed ID: 15380850
[TBL] [Abstract][Full Text] [Related]
8. Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer.
Miyake Y; Mizushima T; Hata T; Takahashi H; Hanada H; Shoji H; Nomura M; Haraguchi N; Nishimura J; Matsuda C; Takemasa I; Doki Y; Maeda I; Mori M; Yamamoto H
Ann Surg Oncol; 2017 Dec; 24(13):3850-3856. PubMed ID: 28924845
[TBL] [Abstract][Full Text] [Related]
9. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
[TBL] [Abstract][Full Text] [Related]
10. 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.
Haseebuddin M; Dehdashti F; Siegel BA; Liu J; Roth EB; Nepple KG; Siegel CL; Fischer KC; Kibel AS; Andriole GL; Miller TR
J Nucl Med; 2013 May; 54(5):699-706. PubMed ID: 23471311
[TBL] [Abstract][Full Text] [Related]
11. PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years.
Shakespeare TP; Eggert E; Wood M; Westhuyzen J; Turnbull K; Rutherford N; Aherne N
Radiother Oncol; 2019 Dec; 141():188-191. PubMed ID: 31668514
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
[TBL] [Abstract][Full Text] [Related]
13. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
14. Mapping of pelvic lymph node metastases in prostate cancer.
Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
[TBL] [Abstract][Full Text] [Related]
15. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
16. Acetone clearance of mesocolic or mesorectal fat increases lymph node yield and may improve detection of high-risk Stage II colorectal cancer patients.
Leung CAW; Fazzi GE; Melenhorst J; Rennspiess D; Grabsch HI
Colorectal Dis; 2018 Nov; 20(11):1014-1019. PubMed ID: 29989291
[TBL] [Abstract][Full Text] [Related]
17. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
[TBL] [Abstract][Full Text] [Related]
18. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
19. Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Kameoka S; Sugihara K
Ann Surg Oncol; 2016 Apr; 23(4):1187-94. PubMed ID: 26671038
[TBL] [Abstract][Full Text] [Related]
20. Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
Fortuin AS; Deserno WM; Meijer HJ; Jager GJ; Takahashi S; Debats OA; Reske SN; Schick C; Krause BJ; van Oort I; Witjes AJ; Hoogeveen YL; van Lin EN; Barentsz JO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):712-8. PubMed ID: 22417806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
